MARCHing onward.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
FACT: ACTUAL PURCHASED CANNABIS PRODUCTS AT DISPENSARIES ARE LABELED FROM ONE SINGLE SAMPLE OF A BULK SUPPLY LEAVING A MARGIN OF ERROR WHEN BROKEN DOWN INTO PARTS AND BECAUSE DISPENSARIES ARE GETTING AWAY WITH LABELING EACH PRODUCT AS THE INITIAL SINGLE BULK TEST, IT IS THE CONSUMERS RESPONSIBILTY TO "TEST & VERIFY" A SAMPLE OF THEIR PURCHASE BEFORE SMOKING IT.
WITH THE RELEASE OF ORGANADX, IT WILL BE THE CONSUMERS RESPONSIBILTY TO "TRUST & VERIFY" A SAMPLE OF THE CANNABIS BEFORE SMOKING IT BECAUSE DUE TO A SLACK IN INDUSTRY REGULATION, THERES A CHANCE THE CONSUMER CAN BE HARMED BY UNAPPROVED PESTICIDES AND THAT IS A RISK NO CONSUMER SHOULD BE FACED WITH AND MYDX HAS THE SOLUTION FOR THAT AS WELL.
IT'S A GREAT ARTICLE TYING ALL OF WHAT MYDX WAS AND WOULD BE TO WHAT IS.
With sp dropping, why isn't volume increasing? Shouldn't it be easier to increase volume with a dropping sp? Interesting isn't it?
REMEMBER THIS?..WELL IT'S COMING TO FRUITION: https://www.newcannabisventures.com/a-new-emerging-growth-driver-in-the-cannabis-industry/
Quote:
"One missing ingredient is the lack of research. Unfortunately, the National Institute of Drug Abuse (NIDA), overseen by the DEA, approves all research studies, and, not surprisingly, the agency is more interested in studies pointing to the evils of cannabis. Fortunately, NIDA has no oversight in Canada, where, with legal medical cannabis, there is a substantial push for research studies. One that caught my attention recently was an arthritis study sponsored by Aphria and Peace Naturals. Aphria, Emerald Health Botanicals, MedReleaf, Peace Naturals and Tilray sponsored a national medical cannabis roundtable discussion in Vancouver in December. The Arthritis Society reports that 65% of people accessing cannabis in Canada through MMPR are doing so to manage arthritis-related pain...This is just one easy target (pain reduction) where cannabis could displace more costly treatment options that can have worse side effects...Cannabis is somewhat of a commodity due to decades of black markets that prevented any sort of intellectual property and continuing challenges due to federal illegality, and the general public is just now learning of some of the different nuances, such as the different cannabinoids and terpenes, the variety of forms (flower, concentrates) , and even the differing methods of consumption (smoke, vaporize, ingest, topical). What we know is changing rapidly, and what we don’t know is becoming painfully obvious. Over the next few years, I expect that we will have more and better information, and those seeking health and wellness benefits will have more reliable data points than anecdotal evidence or word-of-mouth.
Technology will help on this front, whether it is more and better lab tests to understand exactly what is in the products sold or big data applications to correlate the products with outcomes. What MyDx and others, like Potbotics, are doing is a step in the right direction, though these pioneers may wander in the proverbial desert without reaching the Promised Land due to funding issues."
THIS STRAIGHT OUT SAYS THST WHAT MYDX IS DOING IS A STEP IN THE RIGHT DIRECTION. COULDNT AGREE MORE AND MYDX WILL CONTINUE TAKING THOSE STEPS.
HOW MANY TIMES WAS MYDX's TICKER ANNOUNCED IN THE ARTICLE?
MYDX TO PARTNER WITH LICENSED CANADIAN GROWERS ACCORDING THIS PR:
http://www.otcmarkets.com/stock/MYDX/news/MyDx-Launches-Canadian-National-Marketing-Campaign-to-Promote-Transparency-and-Prevent-Abuse-with-Its-CannaDx-Cannabis-Handheld-Chemical-Analyzer?id=162264&b=y
Quote:
"Aphria (APH), one of Canada's largest licensed Marijuana grower's, called on the government to determine "clear and enforceable rules to ensure that customers are protected and have access to clean and safe products." Other licensed producers are also starting to take measures to self-regulate and go above and beyond the regulatory requirements until further defined. The MyDx handheld analyzer for Cannabis (also known as CannaDx) goes hand in hand with those efforts to identify important chemicals profiles and the effects on consumers. This is a very unique opportunity for Canadian producers and MyDx to work together to track feedback from consumers that is tied directly to a chemical profile with over 48,000 datasets collected to date."..."and MYDX 360 which supports access to data for market entrants to compete with larger growers."
Possible MYDX Canadian Partners:
http://herb.co/2017/07/01/cannabis-producers-canada/
OTC IS TRADER'S LIVELIHOOD..TRADERS AND SHORTERS WILL STOP AT NOTHING TO ENSURE INVESTORS LOSE MONEY. UNFORTUNATELY, FOR TRADERS AND SHORTERS PLAYING WITH MYDX, MYDX IS A REAL COMPANY WITH REAL PRODUCTS THAT ARE WORKING THE WAY MYDX INTENDED AND CUSTOMERS ARE UTILIZING THE "TRUST & VERIFY" PROCESS WITH THE ONLY PRODUCT (CANNADX) THAT ALLOWS CUSTOMERS TO TEST A SAMPLE OF THE CANNABIS BEFORE THEY SMOKE IT TO VERIFY THAT IT IS WHAT THEY ARE INTENDING. THIS IS A DISRUPTIVE AND GAME-CHANGING PROCESS SOON TO BE A REQUIREMENT FOR ALL CONSUMERS WHO SMOKE CANNABIS REGULARLY AND ARE RESPONSIBLE WITH WHAT THEY PIT IN THEIR BODIES.
Investors will not be duped into selling 2017
MYDX IS BACKED BY FACT: MYDX CUSTOMERS AND CONSUMERS USING MYDX PRODUCTS ARE BENEFITING FROM ITS USE. THE MYDX APP CONSUMER DATA DOES NOT LIE. THERE IS SIGNIFICANT USER DATA BECAUSE THERE IS A SIGNIFICANT NUMBER OF CANNADX UNITS SOLD AND A SIGNIFICANT AMOUNT OF CANNABIS SAMPLE TESTS CONDUCTED AND COMMUNICATED AMONG CONSUMERS AND POTENTIAL CONSUMERS.
FACT: DISPENSARIES DO NOT TEST EACH INDIVIDUAL PRODUCT SOLD EVEN THOUGH EACH ITEM SOLD IS LABELED WITH A CHEMICAL BREAKDOWN. THE CHEMICAL BREAKDOWN IS BASED ON ONE SAMPLE CONDUCTED ON A LARGE BATCH. THIS LEAVES ROOM FOR A MARGIN OF ERROR. MYDX's CANNADX REMOVES ALL DOUBT OF A MARGIN OF ERROR FOR THE CONSUMER.
MYDX is the solution to an EXPOSED PROBLEM: unsafe black market weed. Before it was just black market weed, this by itself is not effective for MYDX but now that it's UNREGULATED HARMFUL BLACK MARKET WEED, the only chance consumers have of not being harmed by illegal unregulated weed is the MYDX CannaDX chemical analyzer with proven successful results! Once MYDX becomes PREMIER HOUSEHOLD CANNABIS QUALITY CONTROL backed by consumers and consumer confidence, what other companies will be around to compete? What direct competition does MYDX have?
MYDX major reasons why MYDX data is so valuable (followed by reference link):
"However, as MyDx began to analyze the data it accumulated from its testing devices, a much darker picture appeared - you cannot trust what dispensaries sell you."
"Today, if you were to go into any dispensary and ask for "Blue Dream", what do you think you would get? Would you get "Blue Dream"?
According to MyDx data, the answer is unequivocally NO!
Unfortunately, not all Blue Dreams are created equal, unveiling the biggest lie in cannabis. Whereas consumer products outside of cannabis enjoy a higher level of consistency and reliability brought on by stricter enforcement of consumer laws, the same cannot be said about the cannabis industry."
"Fortunately for MyDx users, brand names take a back seat to chemical profiles as MyDx tracks data based on sensory responses, interpreted chemical profiles, and an associated feeling or relief. So while you can't trust the brand name you purchase, you can Trust and Verify® chemical profiles and track how those profiles make you feel using MyDx, which has created another opportunity: green Active Pharmaceuticals Ingredients (gAPI)
"I believe extraction and formulation into a concentrate that can be delivered consistently to help patients find relief for their ailments and symptoms is the next logical step to achieving some level of consistency in the industry," stated Daniel Yazbeck, Chief Executive Officer of MyDx."
http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making
MYDX Why gAPI is so valuable (link reference to follow):
"...we are now identifying the specific green Active Pharmaceutical Ingredients (gAPI) that can be derived from cannabis, as well as the dosage of each ingredient that should go into a formulation so it can be tailored for a specific therapy. This information not only supports an active engaged community, but also provides the basis for our Company to partner, sell and supply smart devices and formulations to the various communities we service so they can benefit from tailored cannabis therapies that meet their specific needs."
http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making
MYDX is HIPPA compliant, important? You be the judge after considering the following (reference links to follow):
"We are finally getting to the heart of what ailments people are tracking and more importantly, what unique chemicals profiles are helping them find relief," stated Yazbeck. "By mining this HIPPA Compliant Data, we are now identifying the specific green Active Pharmaceutical Ingredients (gAPI) that can be derived from cannabis, as well as the dosage of each ingredient that should go into a formulation so it can be tailored for a specific therapy."
http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making
Is HIPPA compliance important (reference link to follow)?
"When dealing with patient ePHI, having a HIPAA compliant provider offers practitioners multiple benefits and peace of mind against impending audits."
http://blog.corespace.com/the-benefits-of-a-hipaa-compliant-provider
Is this product helping consumers determine whether or not they want to smoke a certain strain of cannabis before they smoke it? Is this product helping consumers communicate with MYDX verification that a certain strain could have a certain effect for someone interested in similar results as research before they invest in a cannabis purchase? The answer to these quintessential questions is undoubtedly YES and this is what I love about MYDX and what it is doing for consumers through CannaDX. Big deal if someone tells me a certain strain works for them, I want to be able to test it for myself. MYDX will allow me to test a strain I've had that made me feel sick and caused vomiting and dizziness. I love that I will be able to test what strain that was so I know through the "trust and verify" process that I will never put that strain in my body ever again! This is just cannabis, MYDX is so much more but what it accomplishes is exactly what it set out to do from day one and that is allow consumers the opportunity to "trust and verify" something before they expose it to their bodies, and as far as AeroDX, I believe, there will be sensors you can place in a room that will monitor the air so that before someone enters it, they will be able to know if the air is toxic. For sure, if a room's air is toxic after you enter it, AeroDX will let you know. If someone hates this product or company, it can't be for these reasons, so that's what I will never understand about people who say they hate this company and products. I'm not going to ask questions leading to the conclusion that people involved in companies such as big pharma just don't want MYDX to succeed because it is a threat to their market share in their industry.
It will be the market stimulation most likely from the financials that will drive sp 10x+ with increased investor confidence. INVESTORS ARE NOT SELLING 2017
IM HERE TO OFFER FACTS NOT MAYBE SORTA ALLEGED JUNK. IM NOT HERE TO ANSWER ALL QUESTIONS, THE COMPANY WILL BE HAPPY TO DO ALL THAT.
USER DATA DONT LIE, GOTTA HAVE THE CANNADX TO BUILD A PERSONAL LIBRARY OF SAMPLES THAT GO THROUGH THE "TRUST & VERIFY" PROCESS.
DISPENSARIES DONT TEST EACH PRODUCT SOLD. AS A RESPONSIBLE CONSUMER, I AM AWARE THAT THE DISPENSARY HAS ONE TEST CONDUCTED ON A BULK BATCH AND THEN LABELS EACH BREAKDOWN THE SAME.
CONSUMERS KNOW THERE IS A MARGIN OF ERROR AND DO NOT ASSUME THAT WHAT IS ON THE LABEL IS 100% ACCURATE.
CANNADX SOLVES THE PROBLEM OF MARGIN OF ERROR.
TONS OF USER DATA ON THE MYDX APP SAY ORHERS, get ALL THE FACTS STRAIGHT ABOUT MYDX.
TONS OF PEOPLE BOUGHT AND ARE BUYING MYDX''s CANNADX EXACTLY FOR THIS REASON AND ARE BUILDING A LIBRARY OF SORTS FOR THEMSELVES OF CATALOGUED CANNABIS TESTS FOR THEMSELVES AND OTHERS.
EXPOSED PROBLEM: DISPENSARIES DO NOT TEST A SAMPLE OF EACH CANNABIS SALE -- MARGIN OF ERROR--SOLUTION FOR MARGIN OF ERROR IS MYDX's CANNADX
Cusromers trust that what they are buying is what the label says on the package at dispensaries but as a consumer, it is the consumer's responsibilty to "trust & verify" a sample of each purchase with MYDX's CannaDX.
http://www.prnewswire.com/news-releases/pharma-and-biotech-companies-significantly-investing-in-rd-focus-on-rising-demand-for-advanced-medicines-628164013.html Wow, according to this, est. 50Billion dollars is used by these companies alone are using on R&D investments specifically in "advanced medicine" alone:
"In just over a year ago, it's been estimated $50 billion was invested on pharmaceutical Research and Development activities majorly on oncology, diabetes, and autoimmune therapy classes, which is expected to propel the biotechnology services outsourcing market growth. Biotechnology and Pharmaceutical Companies with developments and recent market activity this week include: Moleculin Biotech, Inc., (NASDAQ: MBRX), XBiotech Inc. (NASDAQ: XBIT), GTx, Inc. (NASDAQ: GTXI), Agenus Inc. (NASDAQ: AGEN) and TrovaGene Inc. (NASDAQ: TROV)"
How many of these companies are applying research to the use of medicinal cannabis in the rising medicinal cannabis market? They are clearly focusing their attention on non-cannabis markets and will go through MYDX when the time is right for them which is most likely when medicinal cannabis is legal at the federal level. The more years, the more they will have to pay for all of MYDX's R&D investments in advanced medicinal cannabis vape pen. What effect will this have on current MYDX investors?
https://www.google.com/amp/s/amp.theguardian.com/us-news/2017/apr/03/big-pharma-marijuana-competition-insys-arizona Why would Big Pharma want to stop something they don't care to get into?
Yep, it's all about cannabis research and research is in Canada and Canada is ahead of US in cannabis research and MYDX is laying a solid foundation in the country that is the forefront of all the research. Great strategy by MYDX:
https://www.leafly.com/news/science-tech/medical-marijuana-research-from-canadian-producers
Of course, US is also researching cannabis but who knows when it will create policy for legalization.
MYDX is taking all the risk because large corporations can just buy their way in:
https://www.google.com/amp/s/www.greenrushdaily.com/apple-not-developing-ivape-vaporizer/amp/
Looks like this tech giant will be billions away and years behind MYDX like other tech giants who don't want to risk what MYDX is already in the process of doing and has already accomplished by creating a company that is selling cannabis related products and becoming cash flow positive. This company will continue to update the public on topics that are important for people to know, for people who want to live a better life. MYDX is the solution and other companies will have to go through MYDX.
How many big tech companies are willing to take the risk in developing a product in the cannabis market? Is it because they know MYDX is already doing it and are cash flow positive already?
How many big pharma companies are developing a medicinal marijuana vape pen that communicates to a device that can be used by doctors to help aid in prescribing remedies for their patients? Is it because they already know MYDX is doing it and is planning on releasing the product to the market by end of year? Are big pharma not taking the risk because they know they can just buy their way into MYDX and go through MYDX? How will all this affect current shareholders?
Big Pharma feeling the Pressure: https://merryjane.com/health/pharmaceutical-companies-are-developing-cannabis-painkillers
Big pharma attempting to minimize future market share loss. This should help drive legislation. Big pharma lobbyists pressuring legislation?
MYDX is the solution to an EXPOSED PROBLEM: unsafe black market weed. Before it was just black market weed, this by itself is not effective for MYDX but now that it's UNREGULATED HARMFUL BLACK MARKET WEED, the only chance consumers have of not being harmed by illegal unregulated weed is the MYDX CannaDX chemical analyzer with proven successful results! Once MYDX becomes PREMIER HOUSEHOLD CANNABIS QUALITY CONTROL backed by consumers and consumer confidence, what other companies will be around to compete? What direct competition does MYDX have?
MYDX major reasons why MYDX data is so valuable (followed by reference link):
"However, as MyDx began to analyze the data it accumulated from its testing devices, a much darker picture appeared - you cannot trust what dispensaries sell you."
"Today, if you were to go into any dispensary and ask for "Blue Dream", what do you think you would get? Would you get "Blue Dream"?
According to MyDx data, the answer is unequivocally NO!
Unfortunately, not all Blue Dreams are created equal, unveiling the biggest lie in cannabis. Whereas consumer products outside of cannabis enjoy a higher level of consistency and reliability brought on by stricter enforcement of consumer laws, the same cannot be said about the cannabis industry."
"Fortunately for MyDx users, brand names take a back seat to chemical profiles as MyDx tracks data based on sensory responses, interpreted chemical profiles, and an associated feeling or relief. So while you can't trust the brand name you purchase, you can Trust and Verify® chemical profiles and track how those profiles make you feel using MyDx, which has created another opportunity: green Active Pharmaceuticals Ingredients (gAPI)
"I believe extraction and formulation into a concentrate that can be delivered consistently to help patients find relief for their ailments and symptoms is the next logical step to achieving some level of consistency in the industry," stated Daniel Yazbeck, Chief Executive Officer of MyDx."
http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making
MYDX Why gAPI is so valuable (link reference to follow):
"...we are now identifying the specific green Active Pharmaceutical Ingredients (gAPI) that can be derived from cannabis, as well as the dosage of each ingredient that should go into a formulation so it can be tailored for a specific therapy. This information not only supports an active engaged community, but also provides the basis for our Company to partner, sell and supply smart devices and formulations to the various communities we service so they can benefit from tailored cannabis therapies that meet their specific needs."
http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making
MYDX is HIPPA compliant, important? You be the judge after considering the following (reference links to follow):
"We are finally getting to the heart of what ailments people are tracking and more importantly, what unique chemicals profiles are helping them find relief," stated Yazbeck. "By mining this HIPPA Compliant Data, we are now identifying the specific green Active Pharmaceutical Ingredients (gAPI) that can be derived from cannabis, as well as the dosage of each ingredient that should go into a formulation so it can be tailored for a specific therapy."
http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making
Is HIPPA compliance important (reference link to follow)?
"When dealing with patient ePHI, having a HIPAA compliant provider offers practitioners multiple benefits and peace of mind against impending audits."
http://blog.corespace.com/the-benefits-of-a-hipaa-compliant-provider
Is this product helping consumers determine whether or not they want to smoke a certain strain of cannabis before they smoke it? Is this product helping consumers communicate with MYDX verification that a certain strain could have a certain effect for someone interested in similar results as research before they invest in a cannabis purchase? The answer to these quintessential questions is undoubtedly YES and this is what I love about MYDX and what it is doing for consumers through CannaDX. Big deal if someone tells me a certain strain works for them, I want to be able to test it for myself. MYDX will allow me to test a strain I've had that made me feel sick and caused vomiting and dizziness. I love that I will be able to test what strain that was so I know through the "trust and verify" process that I will never put that strain in my body ever again! This is just cannabis, MYDX is so much more but what it accomplishes is exactly what it set out to do from day one and that is allow consumers the opportunity to "trust and verify" something before they expose it to their bodies, and as far as AeroDX, I believe, there will be sensors you can place in a room that will monitor the air so that before someone enters it, they will be able to know if the air is toxic. For sure, if a room's air is toxic after you enter it, AeroDX will let you know. If someone hates this product or company, it can't be for these reasons, so that's what I will never understand about people who say they hate this company and products. I'm not going to ask questions leading to the conclusion that people involved in companies such as big pharma just don't want MYDX to succeed because it is a threat to their market share in their industry.
Oh NOOO 5 million shares traded an hour!!!! MYDX was trading 1million shares a minute on average for first thirty minutes of trading in March. Watch what happens with market stimulation. 10x+ current sp in a matter of days!!
MYDX "Trust & Verify" has worked for all consumers offering user data to aid future consumers new to the market. And then they too will "trust & verify"
MYDX APP user data don't lie, FACTS ARE IN FAVOR OF MYDX!!
MYDX APP: Check out all the ailment Remedies, especially PTSD, tons of different strains from users. That means tons of people are using the CannaDX and the App for guidance.
Yep, it's only a matter of time for market stimulation. PROOF IS IN THE USER DATA!!
WOW, 5million shares traded in an hour, MYDX was trading 1Million shares a minute on average for the first 30minutes of trading in March. It was a stimulated market then, it is not a stimulated market now. Watch what happens when the market is stimulated. 10x+ current sp in a matter of days!!!!
For those who have, they have the right to take the proper measures never to have that happen again and MYDX is the only company making it happen.
There's a difference between bad weed as in bad because harmful pesticides on weed can cause health issues if smoked. OrganaDX will be the solution for that potential problem. Consumers will be able to test their weed before smoking it to determine if it is safe through the "trust & verify" process. Not all dispensaries are as regulated as others so it is the customer/consumer's responsibility because it is now public that this is an issue to remedy this potential hazard and the OrganaDX analyzer will solve that problem. However, what I have been referring to about bad weed isn't organically, because yes organically a bad pesticide is bad for all. What I am saying is strains of cannabis, that is the chemical makeup of a sample of cannabis can be tested to determine its TCP. I have the TCP of "Nightmare" so when I test a sample, I know that when it does not match the TCP, then I will not get the bad feelings that "Nightmare" gives me. Now, my "Nigntmare" may not have the same affect on someone else. Someone else can have pleasurable feelings and label it "blue dream" in their catalogue. This is what is fascinating to me. This is why there is no other product like this on the market. Companies, such as Leafly, require a potential consumer to "trust" what someone else says about a certain strain. That same company does not offer a product that can "test & verify" a sample for the customer about to consume that cannabis. My point about buying a strain that is packaged at a dispensary is that it's from a bulk test. Each package was not measured. Customers "trust" that what they are buying actually is what they will be smoking and that may be okay for the majority of customers but I do not have that confidence and I am grateful to have access to the CannaDX to "trust & verify" before smoking something so that I do not worry about whether or not it will be "Nightmare".
To a manufactured perspective and not what actually is. What actually is, is an unstimulated market. A trade ever 5 minutes or longer is not a stimulated market, especially when bid and ask aren't AON.
No maybe about when the market is stimulated, sp will be 10x+ what it is currently.
NO INVESTORS SELLING 2017!!
Consumers have the right to "trust & verify" because the EPOSED PROBLEM is that even regulation is not enough to ensure consumer safety. MYDX takes the random out of spot checks by regulators and allows consumers to "test & verify" each and every time before they smoke a potentially harmful cannabis to ensure its safety.
This is a Toronto vendor selling from its online business since 2003:
https://www.growitall.ca/search?q=Cannabis+analyzer
"Statement from Health Canada on Mandatory Testing of Medical Cannabis for Unauthorized Pesticides"
http://news.morningstar.com/all/printNews.aspx?article=/CNW/20170505C4891_univ.xml
MYDX SOLUTION TO EXPOSED PROBLEM
MYDX is the solution to an EXPOSED PROBLEM: unsafe black market weed. Before it was just black market weed, this by itself is not effective for MYDX but now that it's UNREGULATED HARMFUL BLACK MARKET WEED, the only chance consumers have of not being harmed by illegal unregulated weed is the MYDX CannaDX chemical analyzer with proven successful results! Once MYDX becomes PREMIER HOUSEHOLD CANNABIS QUALITY CONTROL backed by consumers and consumer confidence, what other companies will be around to compete? What direct competition does MYDX have?
MYDX major reasons why MYDX data is so valuable (followed by reference link):
"However, as MyDx began to analyze the data it accumulated from its testing devices, a much darker picture appeared - you cannot trust what dispensaries sell you."
"Today, if you were to go into any dispensary and ask for "Blue Dream", what do you think you would get? Would you get "Blue Dream"?
According to MyDx data, the answer is unequivocally NO!
Unfortunately, not all Blue Dreams are created equal, unveiling the biggest lie in cannabis. Whereas consumer products outside of cannabis enjoy a higher level of consistency and reliability brought on by stricter enforcement of consumer laws, the same cannot be said about the cannabis industry."
"Fortunately for MyDx users, brand names take a back seat to chemical profiles as MyDx tracks data based on sensory responses, interpreted chemical profiles, and an associated feeling or relief. So while you can't trust the brand name you purchase, you can Trust and Verify® chemical profiles and track how those profiles make you feel using MyDx, which has created another opportunity: green Active Pharmaceuticals Ingredients (gAPI)
"I believe extraction and formulation into a concentrate that can be delivered consistently to help patients find relief for their ailments and symptoms is the next logical step to achieving some level of consistency in the industry," stated Daniel Yazbeck, Chief Executive Officer of MyDx."
http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making
MYDX Why gAPI is so valuable (link reference to follow):
"...we are now identifying the specific green Active Pharmaceutical Ingredients (gAPI) that can be derived from cannabis, as well as the dosage of each ingredient that should go into a formulation so it can be tailored for a specific therapy. This information not only supports an active engaged community, but also provides the basis for our Company to partner, sell and supply smart devices and formulations to the various communities we service so they can benefit from tailored cannabis therapies that meet their specific needs."
http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making
MYDX is HIPPA compliant, important? You be the judge after considering the following (reference links to follow):
"We are finally getting to the heart of what ailments people are tracking and more importantly, what unique chemicals profiles are helping them find relief," stated Yazbeck. "By mining this HIPPA Compliant Data, we are now identifying the specific green Active Pharmaceutical Ingredients (gAPI) that can be derived from cannabis, as well as the dosage of each ingredient that should go into a formulation so it can be tailored for a specific therapy."
http://ir.cdxlife.com/press-releases/detail/59/a-problematic-truth-and-a-solution-in-the-making
Is HIPPA compliance important (reference link to follow)?
"When dealing with patient ePHI, having a HIPAA compliant provider offers practitioners multiple benefits and peace of mind against impending audits."
http://blog.corespace.com/the-benefits-of-a-hipaa-compliant-provider
Is this product helping consumers determine whether or not they want to smoke a certain strain of cannabis before they smoke it? Is this product helping consumers communicate with MYDX verification that a certain strain could have a certain effect for someone interested in similar results as research before they invest in a cannabis purchase? The answer to these quintessential questions is undoubtedly YES and this is what I love about MYDX and what it is doing for consumers through CannaDX. Big deal if someone tells me a certain strain works for them, I want to be able to test it for myself. MYDX will allow me to test a strain I've had that made me feel sick and caused vomiting and dizziness. I love that I will be able to test what strain that was so I know through the "trust and verify" process that I will never put that strain in my body ever again! This is just cannabis, MYDX is so much more but what it accomplishes is exactly what it set out to do from day one and that is allow consumers the opportunity to "trust and verify" something before they expose it to their bodies, and as far as AeroDX, I believe, there will be sensors you can place in a room that will monitor the air so that before someone enters it, they will be able to know if the air is toxic. For sure, if a room's air is toxic after you enter it, AeroDX will let you know. If someone hates this product or company, it can't be for these reasons, so that's what I will never understand about people who say they hate this company and products. I'm not going to ask questions leading to the conclusion that people involved in companies such as big pharma just don't want MYDX to succeed because it is a threat to their market share in their industry.
Why wouldn't MYDX want to display their ticker? It is promoting louder the CannaDX anyway. If anything, this gives those interested in buying the product or who have already bought the product and love it a chance to invest in the product they believe in. By investing, they are supporting the company that offers CannaDX which is a very important product to them. How is this not a good thing?
I chose MYDX product because I believe in "trust & verify" as a consumer. I have the right to know the cannabis I am going to smoke is not "Nightmare" and the MYDX app functions via Bluetooth to communicate to me all the data I need to verify and I as well get to communicate to others how different strains affected me. And as an investor, MYDX is the company I chose long before they announced marketing in CANADA.
That video is a year ago. It doesn't look like a product consumers can fit in their back pocket. It doesn't have the marketability that CannaDX has, plus that video has already been posted here before by someone else. It's a nonfactor.
I've never heard of that product, is it displayed in use by real people? Is it being marketed world wide?
Someone already posted that GERMAN product. It looks like it was made during WW2 with spare parts.
I am also an investor in MYDX and as an investor, even though my position is much worse than someone who bought under current sp, I was able to buy at .01 which was and is the lowest possible sp Incan buyin. There is no way with all the movement and the direction that MYDX is going in that this sp remain forever in subpenny. There is a reason why the sp is where it is and it's not because investors are selling their position. Someone mentioned that the majority of shares held are in investors hands. That says a a lot. And investors are continuing to acquire shares along the way but the market has not begun to be stimulated. As soon as the market is stimulated, we will see the sp go up 10x+ from where it is, no doubt about it.
In response to "That is fascinating.." That's what is so great about CannaDX, individuals are affected differently from another individual. It's the individuals responsibilty to determine what strain feels good or bad and other feelings by use of CannaDX. Strains that are known to the consumer to have negative effects are recorded via Bluetooth MYDX app so when a strain with the same tcp comes up after a sample test, the consumer knows not to smoke it. That's how it works for me. Those are my high standards.
Yes, you have to put in the cannabis sample in the compartment and then CannaDX provides the TCP. That's how it works.
That is false and misleading.
Now that it's being used specifically for medicinal purposes moreso than recreational, it has been developing a more sophisticated following. It's no longer cool to be irresponsible and smoke something that makes you vomit.
I wish I had the great brain Yazbeck has, I wish I knew the science behind all of these great devices, but I admit, I do not. But if I had all the resources Yazbeck has and all the capabilities, I would be doing exactly what he is doing. MYDX is the right thing to do and the right direction to go in to help sustain generations to come and help individuals live a better life if. I, as a consumer of many things do not have the ability to "trust and verify" everything I consume but with all the products that MYDX is developing, licensing, whatever people want to call it, is making all this possible for a lot of people who really need it.
Consumers guess they can trust labels, but I for one know I can trust anything that says "Powered By MYDX" and I know I can trust the results of the CannaDX "trust & verify" process. There is no guessing there. And I believe other consumers would agree.
Quite similarly, when consumers read the nutritional facts on anything they buy that is highly regulated, there is still a margin of error. The nutritional facts are an average of the mass production. Consumers are trusting without verifying that they are only putting 350 calories or 5% saturated fat DV in their bodies. Take frozen dinners for instance. Studies have shown pockets of sodium at harmful levels have been detected in individual frozen dinner packets which reveals the flaw in mass production. Sometimes there are harmful margins of error and consumers trust without verifying. THANKS TO MYDX AND ITS CANNADX PRODUCT THIS DOES NOT HAVE TO BE THE CASE WITH THE CANNABIS INDUSTRY. "Trust & verify" should be available for everything that is mass produced so that each consumer knows what they are putting in their bodies.